Jing-Jing Li

11PUBLICATIONS
42CO-AUTHORS
Cancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHaematological tumoursHuman impacts of climate change and human adaptation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 17, 2026
ARID1A Stimulates Notch-TLL1 Signaling to Induce Cancer-Associated Fibroblast Activation and Intrahepatic Cholangiocarcinoma Development.

|Jul 03, 2026
Glucagon-like peptide-1 receptor agonists versus dipeptidyl peptidase-4 inhibitors after liver resection for hepatocellular carcinoma in patients with type 2 diabetes: a target trial emulation study.

|Aug 07, 2025
PPDPF promotes the progression of esophageal squamous cell carcinoma via c-Myc/CD24 axis.

Bing Zhu, Ning Ma, Zhi-Chao Liu

|Jan 19, 2024
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial.

Kang Wang, Yan-Jun Xiang, Hong-Ming Yu

|Dec 14, 2023
XAF1 promotes colorectal cancer metastasis via VCP-RNF114-JUP axis.

Ji Xia, Ning Ma, Qian Shi

|Nov 17, 2022
ARID2 mitigates hepatic steatosis via promoting the ubiquitination of JAK2.

Hui-Jun Cao, Hao Jiang, Kai Ding

Pageof 2

Frequent Collaborators

9 joint publications

Ning Ma

6 joint publications

Dong Xie

4 joint publications

Shuqun Cheng

4 joint publications

Yan-Jun Xiang